FindTrial
Sign In

Effect of RELVAR on asthma COPD overlap syndrome

Effect of RELVAR on asthma COPD overlap syndrome - Effect of RELVAR on ACOS

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014191
Enrollment
20
Registered
2014-06-14
Start date
2014-06-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma COPD overlap syndrome

Interventions

Treatment by Relvar Treatment by Adoair

Sponsors

Respiratory Medicine, Toyama City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: asthma COPD overlap syndrome

Exclusion criteria

Exclusion criteria: without active infection

Design outcomes

Primary

MeasureTime frame
Symptoms evaluated bu QOL quastionare—

Secondary

MeasureTime frame
Respiratory function tests—

Countries

Japan

Contacts

Public ContactYoshihisa Ishiura

Toyama City Hospital Respiratory Medicine

ishiura@tch.toyama.toyama.jp+81-76-422-1112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026